These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 15383738)

  • 1. Decreased release of the angiogenic peptide vascular endothelial growth factor in Alzheimer's disease: recovering effect with insulin and DHEA sulfate.
    Solerte SB; Ferrari E; Cuzzoni G; Locatelli E; Giustina A; Zamboni M; Schifino N; Rondanelli M; Gazzaruso C; Fioravanti M
    Dement Geriatr Cogn Disord; 2005; 19(1):1-10. PubMed ID: 15383738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth factors decrease in subjects with mild to moderate Alzheimer's disease (AD): potential correction with dehydroepiandrosterone-sulphate (DHEAS).
    Luppi C; Fioravanti M; Bertolini B; Inguscio M; Grugnetti A; Guerriero F; Rovelli C; Cantoni F; Guagnano P; Marazzi E; Rolfo E; Ghianda D; Levante D; Guerrini C; Bonacasa R; Solerte SB
    Arch Gerontol Geriatr; 2009; 49 Suppl 1():173-84. PubMed ID: 19836631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dehydroepiandrosterone sulfate enhances natural killer cell cytotoxicity in humans via locally generated immunoreactive insulin-like growth factor I.
    Solerte SB; Fioravanti M; Vignati G; Giustina A; Cravello L; Ferrari E
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3260-7. PubMed ID: 10487697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-accumulation of vascular endothelial growth factor with beta-amyloid in the brain of patients with Alzheimer's disease.
    Yang SP; Bae DG; Kang HJ; Gwag BJ; Gho YS; Chae CB
    Neurobiol Aging; 2004 Mar; 25(3):283-90. PubMed ID: 15123332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of non-steroidal anti-inflammatory drugs on natural killer cell activity in patients with dementia.
    Aizen E; Kagan G; Assy B; Iobel R; Bershadsky Y; Gilhar A
    Isr Med Assoc J; 2005 Feb; 7(2):78-81. PubMed ID: 15729955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloid-β(25-35), an amyloid-β(1-42) surrogate, and proinflammatory cytokines stimulate VEGF-A secretion by cultured, early passage, normoxic adult human cerebral astrocytes.
    Chiarini A; Whitfield J; Bonafini C; Chakravarthy B; Armato U; Dal Prà I
    J Alzheimers Dis; 2010; 21(3):915-26. PubMed ID: 20634577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer's beta-amyloid peptide blocks vascular endothelial growth factor mediated signaling via direct interaction with VEGFR-2.
    Patel NS; Mathura VS; Bachmeier C; Beaulieu-Abdelahad D; Laporte V; Weeks O; Mullan M; Paris D
    J Neurochem; 2010 Jan; 112(1):66-76. PubMed ID: 19818105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defect of a subpopulation of natural killer immune cells in Graves' disease and Hashimoto's thyroiditis: normalizing effect of dehydroepiandrosterone sulfate.
    Solerte SB; Precerutti S; Gazzaruso C; Locatelli E; Zamboni M; Schifino N; Bonacasa R; Rondanelli M; Taccani D; Ferrari E; Fioravanti M
    Eur J Endocrinol; 2005 May; 152(5):703-12. PubMed ID: 15879355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The amyloid-β₄₂ proxy, amyloid-β(25-35), induces normal human cerebral astrocytes to produce amyloid-β₄₂.
    Dal Prà I; Whitfileld JF; Pacchiana R; Bonafini C; Talacchi A; Chakravarthy B; Armato U; Chiarini A
    J Alzheimers Dis; 2011; 24(2):335-47. PubMed ID: 21258151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dehydroepiandrosterone sulfate decreases the interleukin-2-mediated overactivity of the natural killer cell compartment in senile dementia of the Alzheimer type.
    Solerte SB; Fioravanti M; Schifino N; Cuzzoni G; Fontana I; Vignati G; Govoni S; Ferrari E
    Dement Geriatr Cogn Disord; 1999; 10(1):21-7. PubMed ID: 9844034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of human NK cell lines by vascular endothelial growth factor and receptor VEGFR-1 (FLT-1).
    Chen WS; Kitson RP; Goldfarb RH
    In Vivo; 2002; 16(6):439-45. PubMed ID: 12494887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific interaction of VEGF165 with beta-amyloid, and its protective effect on beta-amyloid-induced neurotoxicity.
    Yang SP; Kwon BO; Gho YS; Chae CB
    J Neurochem; 2005 Apr; 93(1):118-27. PubMed ID: 15773911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral glucose loading modulates plasma β-amyloid level in alzheimer's disease patients: potential diagnostic method for Alzheimer's disease.
    Takeda S; Sato N; Uchio-Yamada K; Yu H; Moriguchi A; Rakugi H; Morishita R
    Dement Geriatr Cogn Disord; 2012; 34(1):25-30. PubMed ID: 22889768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer's disease and the 'ABSENT' hypothesis: mechanism for amyloid beta endothelial and neuronal toxicity.
    Roy S; Rauk A
    Med Hypotheses; 2005; 65(1):123-37. PubMed ID: 15893129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum paraoxonase activity changes in patients with Alzheimer's disease and vascular dementia.
    Paragh G; Balla P; Katona E; Seres I; Egerházi A; Degrell I
    Eur Arch Psychiatry Clin Neurosci; 2002 Apr; 252(2):63-7. PubMed ID: 12111338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of encapsulated VEGF-secreting cells on brain amyloid load and behavioral impairment in a mouse model of Alzheimer's disease.
    Spuch C; Antequera D; Portero A; Orive G; Hernández RM; Molina JA; Bermejo-Pareja F; Pedraz JL; Carro E
    Biomaterials; 2010 Jul; 31(21):5608-18. PubMed ID: 20430437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma amyloid-beta forms in Alzheimer's disease and non-Alzheimer's disease patients.
    Le Bastard N; Leurs J; Blomme W; De Deyn PP; Engelborghs S
    J Alzheimers Dis; 2010; 21(1):291-301. PubMed ID: 20421698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aging promotes amyloid-β peptide induced mitochondrial dysfunctions in rat brain: a molecular link between aging and Alzheimer's disease.
    Sinha M; Behera P; Bhowmick P; Banerjee K; Basu S; Chakrabarti S
    J Alzheimers Dis; 2011; 27(4):753-65. PubMed ID: 21876248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dehydroepiandrosterone-sulfate (DHEA-S) restores the release of IGF-I from natural killer (NK) immune in old patients with dementia of Alzheimer's type (DAT).
    Solerte SB; Gornati R; Cravello L; Albertelli N; Oberti S; Perotta D; Rossi G; Cuzzoni G; Ferrari E; Fioravanti M
    J Endocrinol Invest; 1999; 22(10 Suppl):32-4. PubMed ID: 10727032
    [No Abstract]   [Full Text] [Related]  

  • 20. Low serum VEGF levels are associated with Alzheimer's disease.
    Mateo I; Llorca J; Infante J; Rodríguez-Rodríguez E; Fernández-Viadero C; Peña N; Berciano J; Combarros O
    Acta Neurol Scand; 2007 Jul; 116(1):56-8. PubMed ID: 17587256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.